{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:28:36Z","timestamp":1791379716502,"version":"4.3.3"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ypmed.2011.08.017","type":"journal-article","created":{"date-parts":[[2011,10,2]],"date-time":"2011-10-02T06:42:49Z","timestamp":1317537769000},"page":"S12-S21","source":"Crossref","is-referenced-by-count":196,"special_numbering":"S1","title":["Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies"],"prefix":"10.1016","volume":"53","author":[{"given":"Joseph E.","family":"Tota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Chevarie-Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsay A.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"deVries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo L.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ypmed.2011.08.017_bb0005","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00007435-200209000-00006","article-title":"A stratified approach to untangling the behavioral\/biomedical outcomes conundrum","volume":"29","author":"Aral","year":"2002","journal-title":"Sex. Transm. Dis."},{"issue":"Suppl. 3","key":"10.1016\/j.ypmed.2011.08.017_bb0010","first-page":"S378","article-title":"Chapter 9: clinical applications of HPV testing: a summary of meta-analyses","volume":"24","author":"Arbyn","year":"2006","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.ypmed.2011.08.017_bb0015","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.ejca.2009.07.018","article-title":"Trends of cervical cancer mortality in the member states of the European Union","volume":"45","author":"Arbyn","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ypmed.2011.08.017_bb0020","doi-asserted-by":"crossref","unstructured":"Arbyn, M., Castellsague, X., de Sanjose, S., et al., in press. Worldwide burden of cervical cancer in 2008. Ann. Oncol. Apr 6 (Electronic publication ahead of print). doi:10.1093\/annonc\/mdr015.","DOI":"10.1093\/annonc\/mdr015"},{"issue":"1","key":"10.1016\/j.ypmed.2011.08.017_bb0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/595566","article-title":"Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa","volume":"199","author":"Auvert","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.ypmed.2011.08.017_bb0030","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.olq.0000140012.02703.10","article-title":"Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic","volume":"31","author":"Baldwin","year":"2004","journal-title":"Sex. Transm. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.ypmed.2011.08.017_bb0035","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jcv.2004.12.008","article-title":"The epidemiology of human papillomavirus infections","volume":"32","author":"Baseman","year":"2005","journal-title":"J. Clin. Virol."},{"issue":"5","key":"10.1016\/j.ypmed.2011.08.017_bb0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00007435-199309000-00007","article-title":"Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon","volume":"20","author":"Bauer","year":"1993","journal-title":"Sex. Transm. Dis."},{"issue":"11","key":"10.1016\/j.ypmed.2011.08.017_bb0045","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group","volume":"87","author":"Bosch","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"issue":"9783","key":"10.1016\/j.ypmed.2011.08.017_bb0050","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","article-title":"Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study","volume":"377","author":"Brotherton","year":"2011","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ypmed.2011.08.017_bb0055","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16\u201326years","volume":"199","author":"Brown","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.ypmed.2011.08.017_bb0060","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.ypmed.2011.08.017_bb0065","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1371\/journal.ppat.0020069","article-title":"Carrageenan is a potent inhibitor of papillomavirus infection","volume":"2","author":"Buck","year":"2006","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.ypmed.2011.08.017_bb0070","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.20076","article-title":"POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women","volume":"110","author":"Bulkmans","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"9601","key":"10.1016\/j.ypmed.2011.08.017_bb0075","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ypmed.2011.08.017_bb0080","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/aje\/kwj077","article-title":"Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada","volume":"163","author":"Burchell","year":"2006","journal-title":"Am. J. Epidemiol."},{"issue":"15","key":"10.1016\/j.ypmed.2011.08.017_bb0085","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa011688","article-title":"Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners","volume":"346","author":"Castellsague","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 3","key":"10.1016\/j.ypmed.2011.08.017_bb0090","doi-asserted-by":"crossref","first-page":"S345","DOI":"10.1590\/S0036-36342003000900008","article-title":"The male role in cervical cancer","volume":"45","author":"Castellsague","year":"2003","journal-title":"Salud Publica Mex."},{"issue":"11","key":"10.1016\/j.ypmed.2011.08.017_bb0095","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1086\/428779","article-title":"A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica","volume":"191","author":"Castle","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"4 Suppl.","key":"10.1016\/j.ypmed.2011.08.017_bb0100","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jadohealth.2010.01.016","article-title":"Beyond cervical cancer: burden of other HPV-related cancers among men and women","volume":"46","author":"Chaturvedi","year":"2010","journal-title":"J. Adolesc. Health"},{"issue":"10","key":"10.1016\/j.ypmed.2011.08.017_bb0105","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1158\/1055-9965.EPI-05-0465","article-title":"Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections","volume":"14","author":"Chaturvedi","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"4","key":"10.1016\/j.ypmed.2011.08.017_bb0110","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2007.14.1713","article-title":"Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States","volume":"26","author":"Chaturvedi","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ypmed.2011.08.017_bb0115","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1086\/425906","article-title":"Age-specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study","volume":"190","author":"Chin-Hong","year":"2004","journal-title":"J. Infect. Dis."},{"issue":"9490","key":"10.1016\/j.ypmed.2011.08.017_bb0120","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","article-title":"Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis","volume":"366","author":"Clifford","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ypmed.2011.08.017_bb0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/sj.bjc.6603822","article-title":"Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women","volume":"97","author":"Cotton","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.ypmed.2011.08.017_bb0130","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.ypmed.2011.08.017_bb0135","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"de Sanjose","year":"2007","journal-title":"Lancet Infect. Dis."},{"issue":"11","key":"10.1016\/j.ypmed.2011.08.017_bb0140","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"issue":"Suppl. 3","key":"10.1016\/j.ypmed.2011.08.017_bb0145","first-page":"S3\/71","article-title":"Chapter 8: screening for cervical cancer in developing countries","volume":"24","author":"Denny","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ypmed.2011.08.017_bb0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ijc.22667","article-title":"Six-month natural history of oral versus cervical human papillomavirus infection","volume":"121","author":"D'Souza","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"19","key":"10.1016\/j.ypmed.2011.08.017_bb0155","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1056\/NEJMoa065497","article-title":"Case\u2013control study of human papillomavirus and oropharyngeal cancer","volume":"356","author":"D'Souza","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ypmed.2011.08.017_bb0160","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1086\/597755","article-title":"Oral sexual behaviors associated with prevalent oral human papillomavirus infection","volume":"199","author":"D'Souza","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.ypmed.2011.08.017_bb0165","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ypmed.2011.08.017_bb0170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/sti.2003.008300","article-title":"Sexual behaviour: related adverse health burden in the United States","volume":"81","author":"Ebrahim","year":"2005","journal-title":"Sex. Transm. Infect."},{"issue":"3 Pt 1","key":"10.1016\/j.ypmed.2011.08.017_bb0175","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ajog.2005.01.056","article-title":"Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence","volume":"193","author":"Elfgren","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ypmed.2011.08.017_bb0180","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.humimm.2011.01.010","article-title":"Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence","volume":"72","author":"Ferguson","year":"2011","journal-title":"Hum. Immunol."},{"issue":"11","key":"10.1016\/j.ypmed.2011.08.017_bb0185","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/ijc.22241","article-title":"Variations in the age-specific curves of human papillomavirus prevalence in women worldwide","volume":"119","author":"Franceschi","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.ypmed.2011.08.017_bb0190","first-page":"759","article-title":"Understanding the epidemiology of genital infection with oncogenic and nononcogenic human papillomaviruses: a promising lead for primary prevention of cervical cancer","volume":"6","author":"Franco","year":"1997","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"3","key":"10.1016\/j.ypmed.2011.08.017_bb0195","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/infdis\/172.3.756","article-title":"Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk types","volume":"172","author":"Franco","year":"1995","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.ypmed.2011.08.017_bb0200","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1086\/315086","article-title":"Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer","volume":"180","author":"Franco","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 3","key":"10.1016\/j.ypmed.2011.08.017_bb0205","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1590\/S0036-36342003000900011","article-title":"Prospects for controlling cervical cancer at the turn of the century","volume":"45","author":"Franco","year":"2003","journal-title":"Salud Publica Mex."},{"issue":"Suppl. 11","key":"10.1016\/j.ypmed.2011.08.017_bb0210","doi-asserted-by":"crossref","first-page":"L88","DOI":"10.1016\/j.vaccine.2008.05.026","article-title":"Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean","volume":"26","author":"Franco","year":"2008","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ypmed.2011.08.017_bb0215","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hed.20573","article-title":"Current topics in the epidemiology of oral cavity and oropharyngeal cancers","volume":"29","author":"Gillison","year":"2007","journal-title":"Head Neck"},{"issue":"4 Suppl.","key":"10.1016\/j.ypmed.2011.08.017_bb0220","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.jadohealth.2008.07.002","article-title":"Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination","volume":"43","author":"Gillison","year":"2008","journal-title":"J. Adolesc. Health"},{"issue":"6","key":"10.1016\/j.ypmed.2011.08.017_bb0225","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jnci\/djn025","article-title":"Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers","volume":"100","author":"Gillison","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"issue":"10 Suppl.","key":"10.1016\/j.ypmed.2011.08.017_bb0230","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/cncr.23764","article-title":"HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women","volume":"113","author":"Gillison","year":"2008","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ypmed.2011.08.017_bb0235","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1086\/379197","article-title":"Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig\u2013McGill HPV natural history study","volume":"188","author":"Giuliano","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 10","key":"10.1016\/j.ypmed.2011.08.017_bb0240","doi-asserted-by":"crossref","first-page":"K17","DOI":"10.1016\/j.vaccine.2008.06.021","article-title":"Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions","volume":"26","author":"Giuliano","year":"2008","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.ypmed.2011.08.017_bb0245","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"32","key":"10.1016\/j.ypmed.2011.08.017_bb0250","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1016\/j.vaccine.2008.04.053","article-title":"Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries","volume":"26","author":"Goldie","year":"2008","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.ypmed.2011.08.017_bb0255","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1158\/1055-9965.EPI-10-0645","article-title":"Behavioral\/lifestyle and immunologic factors associated with HPV infection among women older than 45years","volume":"19","author":"Gonzalez","year":"2010","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"7","key":"10.1016\/j.ypmed.2011.08.017_bb0260","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1086\/529207","article-title":"Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV cohort study","volume":"197","author":"Goodman","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"9518","key":"10.1016\/j.ypmed.2011.08.017_bb0265","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ypmed.2011.08.017_bb0270","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/ije\/dyp350","article-title":"Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium","volume":"39","author":"Heck","year":"2010","journal-title":"Int. J. Epidemiol."},{"issue":"11 Pt 1","key":"10.1016\/j.ypmed.2011.08.017_bb0275","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1158\/1055-9965.EPI-05-0460","article-title":"Anal human papillomavirus infection in women and its relationship with cervical infection","volume":"14","author":"Hernandez","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"6","key":"10.1016\/j.ypmed.2011.08.017_bb0280","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3201\/eid1406.070616.2","article-title":"Transmission of human papillomavirus in heterosexual couples","volume":"14","author":"Hernandez","year":"2008","journal-title":"Emerg. Infect. Dis."},{"issue":"23","key":"10.1016\/j.ypmed.2011.08.017_bb0285","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/jnci\/djg107","article-title":"Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study","volume":"95","author":"Herrero","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.ypmed.2011.08.017_bb0290","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1086\/428850","article-title":"Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica","volume":"191","author":"Herrero","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.ypmed.2011.08.017_bb0295","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/infdis\/169.2.235","article-title":"Persistence of type-specific human papillomavirus infection among cytologically normal women","volume":"169","author":"Hildesheim","year":"1994","journal-title":"J. Infect. Dis."},{"issue":"18","key":"10.1016\/j.ypmed.2011.08.017_bb0300","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/87.18.1365","article-title":"Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia","volume":"87","author":"Ho","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.ypmed.2011.08.017_bb0305","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2011.08.017_bb0310","series-title":"Human Papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans","author":"IARC","year":"2005"},{"key":"10.1016\/j.ypmed.2011.08.017_bb0315","series-title":"Human Papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans","author":"IARC","year":"2011"},{"issue":"3","key":"10.1016\/j.ypmed.2011.08.017_bb0320","doi-asserted-by":"crossref","first-page":"e9584","DOI":"10.1371\/journal.pone.0009584","article-title":"Declining death rates reflect progress against cancer","volume":"5","author":"Jemal","year":"2010","journal-title":"PLoS One"},{"issue":"3 Suppl. 1","key":"10.1016\/j.ypmed.2011.08.017_bb0325","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.ygyno.2008.06.027","article-title":"A review of cross-protection against oncogenic HPV by an HPV-16\/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention","volume":"110","author":"Jenkins","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ypmed.2011.08.017_bb0330","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1542\/peds.109.1.e5","article-title":"Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection","volume":"109","author":"Kahn","year":"2002","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.ypmed.2011.08.017_bb0335","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(09)70156-1","article-title":"HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial","volume":"10","author":"Kitchener","year":"2009","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.ypmed.2011.08.017_bb0340","first-page":"799","article-title":"Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types?","volume":"6","author":"Kjaer","year":"1997","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"8","key":"10.1016\/j.ypmed.2011.08.017_bb0345","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00007435-200009000-00003","article-title":"Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity","volume":"27","author":"Kjaer","year":"2000","journal-title":"Sex. Transm. Dis."},{"issue":"7364","key":"10.1016\/j.ypmed.2011.08.017_bb0350","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/bmj.325.7364.572","article-title":"Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study","volume":"325","author":"Kjaer","year":"2002","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ypmed.2011.08.017_bb0355","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1158\/1055-9965.EPI-04-0754","article-title":"Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers","volume":"14","author":"Kjaer","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"8","key":"10.1016\/j.ypmed.2011.08.017_bb0360","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/sj.bjc.6602799","article-title":"Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting","volume":"93","author":"Kotaniemi-Talonen","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ypmed.2011.08.017_bb0365","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/oxfordjournals.epirev.a036020","article-title":"Epidemiology of genital human papillomavirus infection","volume":"10","author":"Koutsky","year":"1988","journal-title":"Epidemiol. Rev."},{"issue":"18","key":"10.1016\/j.ypmed.2011.08.017_bb0370","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199210293271804","article-title":"A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection","volume":"327","author":"Koutsky","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ypmed.2011.08.017_bb0375","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","article-title":"Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review","volume":"14","author":"Kreimer","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"7","key":"10.1016\/j.ypmed.2011.08.017_bb0380","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/1055-9965.EPI-04-0926","article-title":"Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men","volume":"14","author":"Lajous","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"3","key":"10.1016\/j.ypmed.2011.08.017_bb0385","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/1097-0215(20010201)91:3<412::AID-IJC1071>3.0.CO;2-M","article-title":"Epidemiology of HPV infection among Mexican women with normal cervical cytology","volume":"91","author":"Lazcano-Ponce","year":"2001","journal-title":"Int. J. Cancer"},{"issue":"23","key":"10.1016\/j.ypmed.2011.08.017_bb0390","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/jnci\/djp367","article-title":"Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting","volume":"101","author":"Leinonen","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.ypmed.2011.08.017_bb0395","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication","volume":"128","author":"Li","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.ypmed.2011.08.017_bb0400","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/jnci\/91.11.954","article-title":"Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions","volume":"91","author":"Liaw","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ypmed.2011.08.017_bb0405","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1086\/317638","article-title":"A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types","volume":"183","author":"Liaw","year":"2001","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.ypmed.2011.08.017_bb0410","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1447-0756.1996.tb01081.x","article-title":"Hybrid capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening","volume":"22","author":"Lorincz","year":"1996","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"3","key":"10.1016\/j.ypmed.2011.08.017_bb0415","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00006250-199203000-00002","article-title":"Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types","volume":"79","author":"Lorincz","year":"1992","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.ypmed.2011.08.017_bb0420","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00002030-200003310-00009","article-title":"Partner type and condom use","volume":"14","author":"Macaluso","year":"2000","journal-title":"AIDS (London, England)"},{"issue":"2","key":"10.1016\/j.ypmed.2011.08.017_bb0425","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1086\/341080","article-title":"Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection","volume":"186","author":"Maciag","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.ypmed.2011.08.017_bb0430","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00007435-200211000-00018","article-title":"Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis","volume":"29","author":"Manhart","year":"2002","journal-title":"Sex. Transm. Dis."},{"issue":"6","key":"10.1016\/j.ypmed.2011.08.017_bb0435","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2105\/AJPH.91.6.947","article-title":"Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women","volume":"91","author":"Marrazzo","year":"2001","journal-title":"Am. J. Public Health"},{"issue":"16","key":"10.1016\/j.ypmed.2011.08.017_bb0440","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ypmed.2011.08.017_bb0445","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0463.2010.2602.x","article-title":"Multiple human papilloma virus types in cervical infections: competition or synergy?","volume":"118","author":"Mejlhede","year":"2010","journal-title":"APMIS"},{"issue":"7","key":"10.1016\/j.ypmed.2011.08.017_bb0450","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1086\/444391","article-title":"Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines","volume":"192","author":"Mendez","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ypmed.2011.08.017_bb0455","article-title":"Differences in incidence and co-occurrence of vaccine and non-vaccine human papillomavirus (HPV) types in Finnish population before HPV mass vaccination suggest competitive advantage for HPV33","volume":"13","author":"Merikukka","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.ypmed.2011.08.017_bb0460","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/aje\/kwg171","article-title":"Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study","volume":"158","author":"Molano","year":"2003","journal-title":"Am. J. Epidemiol."},{"issue":"2 Suppl. 1","key":"10.1016\/j.ypmed.2011.08.017_bb0465","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.ygyno.2007.07.076","article-title":"The spectrum and clinical sequelae of human papillomavirus infection","volume":"107","author":"Monk","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ypmed.2011.08.017_bb0470","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0022-3476(98)70445-7","article-title":"The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women","volume":"132","author":"Moscicki","year":"1998","journal-title":"J. Pediatr."},{"issue":"23","key":"10.1016\/j.ypmed.2011.08.017_bb0475","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1001\/jama.285.23.2995","article-title":"Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females","volume":"285","author":"Moscicki","year":"2001","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ypmed.2011.08.017_bb0480","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"9777","key":"10.1016\/j.ypmed.2011.08.017_bb0485","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/S0140-6736(11)60622-3","article-title":"Financing HPV vaccination in developing countries","volume":"377","year":"2011","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ypmed.2011.08.017_bb0490","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review","volume":"132","author":"Nanda","year":"2000","journal-title":"Ann. Intern. Med."},{"issue":"16","key":"10.1016\/j.ypmed.2011.08.017_bb0495","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ypmed.2011.08.017_bb0500","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jnci\/djn444","article-title":"Efficacy of HPV DNA testing with cytology triage and\/or repeat HPV DNA testing in primary cervical cancer screening","volume":"101","author":"Naucler","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.ypmed.2011.08.017_bb0505","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1158\/1055-9965.EPI-06-0997","article-title":"Human papillomavirus prevalence and type distribution in male anogenital sites and semen","volume":"16","author":"Nielson","year":"2007","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"9172","key":"10.1016\/j.ypmed.2011.08.017_bb0510","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0140-6736(98)12490-X","article-title":"Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study","volume":"354","author":"Nobbenhuis","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ypmed.2011.08.017_bb0515","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","article-title":"Natural history of cervical intraepithelial neoplasia: a critical review","volume":"12","author":"Ostor","year":"1993","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"9686","key":"10.1016\/j.ypmed.2011.08.017_bb0520","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ypmed.2011.08.017_bb0525","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/318071","article-title":"Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women","volume":"183","author":"Palefsky","year":"2001","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.ypmed.2011.08.017_bb0530","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.ypmed.2011.08.017_bb0535","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/521192","article-title":"Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students","volume":"196","author":"Partridge","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.ypmed.2011.08.017_bb0540","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/jnci\/djr053","article-title":"For cancers caused by HPV, two vaccines were just the beginning","volume":"103","author":"Peres","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.ypmed.2011.08.017_bb0545","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/516784","article-title":"A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion","volume":"195","author":"Plummer","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ypmed.2011.08.017_bb0550","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/1471-2334-10-326","article-title":"Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women","volume":"10","author":"Ramanakumar","year":"2010","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"10.1016\/j.ypmed.2011.08.017_bb0555","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ijc.2910610305","article-title":"The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36months","volume":"61","author":"Remmink","year":"1995","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.ypmed.2011.08.017_bb0560","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00007435-200002000-00005","article-title":"Determinants of low-risk and high-risk cervical human papillomavirus infections in Montreal University students","volume":"27","author":"Richardson","year":"2000","journal-title":"Sex. Transm. Dis."},{"issue":"6","key":"10.1016\/j.ypmed.2011.08.017_bb0565","first-page":"485","article-title":"The natural history of type-specific human papillomavirus infections in female university students","volume":"12","author":"Richardson","year":"2003","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"7","key":"10.1016\/j.ypmed.2011.08.017_bb0570","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nm1598","article-title":"Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan","volume":"13","author":"Roberts","year":"2007","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.ypmed.2011.08.017_bb0575","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/jnci\/djr061","article-title":"Effect of pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model","volume":"103","author":"Roberts","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.ypmed.2011.08.017_bb0580","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1470-2045(06)70731-8","article-title":"Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35years: results at recruitment for a randomised controlled trial","volume":"7","author":"Ronco","year":"2006","journal-title":"Lancet Oncol."},{"issue":"7609","key":"10.1016\/j.ypmed.2011.08.017_bb0585","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.39196.740995.BE","article-title":"Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial","volume":"335","author":"Ronco","year":"2007","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.ypmed.2011.08.017_bb0590","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/jnci\/djn065","article-title":"Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test","volume":"100","author":"Ronco","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.ypmed.2011.08.017_bb0595","first-page":"469","article-title":"A cumulative case\u2013control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections","volume":"9","author":"Rousseau","year":"2000","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"12","key":"10.1016\/j.ypmed.2011.08.017_bb0600","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1086\/324579","article-title":"Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection","volume":"184","author":"Rousseau","year":"2001","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.ypmed.2011.08.017_bb0605","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00007435-200307000-00010","article-title":"Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities","volume":"30","author":"Rousseau","year":"2003","journal-title":"Sex. Transm. Dis."},{"issue":"14","key":"10.1016\/j.ypmed.2011.08.017_bb0610","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"9590","key":"10.1016\/j.ypmed.2011.08.017_bb0615","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2011.08.017_bb0620","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-9378-4-8","article-title":"Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline","volume":"4","author":"Schiffman","year":"2009","journal-title":"Infect. Agent Cancer"},{"issue":"5","key":"10.1016\/j.ypmed.2011.08.017_bb0625","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/djq562","article-title":"Human papillomavirus testing in the prevention of cervical cancer","volume":"103","author":"Schiffman","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"issue":"24","key":"10.1016\/j.ypmed.2011.08.017_bb0630","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1001\/jama.286.24.3106","article-title":"Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia","volume":"286","author":"Schlecht","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ypmed.2011.08.017_bb0635","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ijc.10846","article-title":"Viral load as a predictor of the risk of cervical intraepithelial neoplasia","volume":"103","author":"Schlecht","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.ypmed.2011.08.017_bb0640","first-page":"421","article-title":"Incidence, clearance and predictors of human papillomavirus infection in women","volume":"168","author":"Sellors","year":"2003","journal-title":"CMAJ"},{"issue":"6","key":"10.1016\/j.ypmed.2011.08.017_bb0645","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/cncr.20877","article-title":"Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival","volume":"103","author":"Sherman","year":"2005","journal-title":"Cancer"},{"issue":"4 Suppl.","key":"10.1016\/j.ypmed.2011.08.017_bb0650","first-page":"S5","article-title":"Age-specific prevalence of infection with human papillomavirus in females: a global review","volume":"43","author":"Smith","year":"2008","journal-title":"J. Adolesc. Health"},{"issue":"2","key":"10.1016\/j.ypmed.2011.08.017_bb0655","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ijc.24770","article-title":"Prevalence and risk factors of human papillomavirus infection by penile site in uncircumcised Kenyan men","volume":"126","author":"Smith","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.ypmed.2011.08.017_bb0660","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jadohealth.2011.03.010","article-title":"Age-specific prevalence of human papillomavirus infection in males: a global review","volume":"48","author":"Smith","year":"2011","journal-title":"J. Adolesc. Health"},{"issue":"5","key":"10.1016\/j.ypmed.2011.08.017_bb0665","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/sti.75.5.317","article-title":"Detection of human papillomavirus DNA on the fingers of patients with genital warts","volume":"75","author":"Sonnex","year":"1999","journal-title":"Sex. Transm. Infect."},{"issue":"10","key":"10.1016\/j.ypmed.2011.08.017_bb0670","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1158\/1055-9965.EPI-10-0424","article-title":"Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix","volume":"19","author":"Sundstrom","year":"2010","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"4","key":"10.1016\/j.ypmed.2011.08.017_bb0675","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1086\/315805","article-title":"Concurrent and sequential acquisition of different genital human papillomavirus types","volume":"182","author":"Thomas","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"13","key":"10.1016\/j.ypmed.2011.08.017_bb0680","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa0802556","article-title":"Male circumcision for the prevention of HSV-2 and HPV infections and syphilis","volume":"360","author":"Tobian","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ypmed.2011.08.017_bb0685","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1071\/SH10022","article-title":"Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era","volume":"7","author":"Tota","year":"2010","journal-title":"Sex. Health"},{"issue":"1","key":"10.1016\/j.ypmed.2011.08.017_bb0690","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0029-7844(97)00593-0","article-title":"Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery","volume":"91","author":"Tseng","year":"1998","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ypmed.2011.08.017_bb0695","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1158\/1055-9965.EPI-09-0983","article-title":"Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV prevalence surveys","volume":"19","author":"Vaccarella","year":"2010","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"1","key":"10.1016\/j.ypmed.2011.08.017_bb0700","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/infdis\/jiq015","article-title":"External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents","volume":"203","author":"Vardas","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.ypmed.2011.08.017_bb0705","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U","article-title":"International trends in the incidence of cervical cancer: I. adenocarcinoma and adenosquamous cell carcinomas","volume":"75","author":"Vizcaino","year":"1998","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ypmed.2011.08.017_bb0710","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.ypmed.2011.08.017_bb0715","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/aje\/kwh044","article-title":"Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status","volume":"159","author":"Warner","year":"2004","journal-title":"Am. J. Epidemiol."},{"issue":"9761","key":"10.1016\/j.ypmed.2011.08.017_bb0720","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(10)61967-8","article-title":"Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda","volume":"377","author":"Wawer","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ypmed.2011.08.017_bb0725","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1086\/381395","article-title":"Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men","volume":"189","author":"Weaver","year":"2004","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ypmed.2011.08.017_bb0730","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwf180","article-title":"Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students","volume":"157","author":"Winer","year":"2003","journal-title":"Am. J. Epidemiol."},{"issue":"25","key":"10.1016\/j.ypmed.2011.08.017_bb0735","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa053284","article-title":"Condom use and the risk of genital human papillomavirus infection in young women","volume":"354","author":"Winer","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2011.08.017_bb0740","doi-asserted-by":"crossref","unstructured":"Wong, C.A., Berkowitz, Z., Dorell, C.G., et al., in press. Human papillomavirus vaccine uptake among 9- to 17-year-old girls: national health interview survey, 2008. Cancer Jun 20 (Epub ahead of print). doi:10.1002\/cncr.26246.","DOI":"10.1002\/cncr.26246"},{"issue":"21","key":"10.1016\/j.ypmed.2011.08.017_bb0745","first-page":"6027","article-title":"A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ","volume":"60","author":"Ylitalo","year":"2000","journal-title":"Cancer Res."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743511003069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743511003069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,16]],"date-time":"2019-06-16T18:10:23Z","timestamp":1560708623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743511003069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":149,"alternative-id":["S0091743511003069"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2011.08.017","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}